Search

everythinglearnresearchcommunity

for

Search:↓

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

People with alopecia areata often have lower iron levels than healthy people.

Androgen lowering medications don't significantly change HCV-related liver cancer risk in men.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

The document concludes that secondary syphilis cases are increasing and often misdiagnosed, pityriasis rubra pilaris can be distinguished from psoriasis by skin cell features, and different skin layers produce specific components during skin repair.

Cyclophosphamide helped 59.4% of children with steroid-resistant nephrotic syndrome but caused side effects in 40.6%.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Children with scalp fungal infections need proper diagnosis and treatment, usually with antifungal medications, and newer drugs may offer quicker recovery.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Combined minoxidil and tretinoin solution works as well as regular minoxidil for male hair loss.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Suppressing certain hormones might help prevent prostate cancer.

Photodynamic therapy is the preferred treatment for skin precancer due to its effectiveness and safety.

Polygonum multiflorum can promote hair growth when taken orally or applied topically.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Gelatin microspheres with stem cells speed up healing in diabetic wounds.

The position of the parietal whorl can predict safe donor areas for hair transplants in Korean men with male pattern baldness.

Patients with hair loss are much more likely to have body dysmorphic disorder than general dermatology patients.

Finasteride 5-mg oral disintegrating tablets and standard tablets are bioequivalent in healthy adult male Han Chinese volunteers.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.